Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Boston Scientific Corporation
Boston Scientific Corporation
Pfizer
National Cancer Center Hospital East
Centre Paul Strauss
IDRx Inc. - A GSK Company
Dartmouth-Hitchcock Medical Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Pfizer
Hoffmann-La Roche
Thomas Jefferson University
Thomas Jefferson University
Revolution Medicines, Inc.
University of Alberta
Imunon
University of Aarhus
NanOlogy, LLC
Theseus Pharmaceuticals
University Medical Center Groningen
Kyowa Kirin Co., Ltd.
Taipei Veterans General Hospital, Taiwan
University Hospital, Antwerp
Catalysis SL
Catalysis SL
Qure Healthcare, LLC
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
The First Affiliated Hospital with Nanjing Medical University
The Second Affiliated Hospital of Fujian Medical University
Celgene
Catalysis SL
Jiangxi Provincial Cancer Hospital
Revolution Medicines, Inc.
Zhejiang University
H. Lee Moffitt Cancer Center and Research Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cedars-Sinai Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Isofol Medical AB
Lund University Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Portsmouth Hospitals NHS Trust
Royal Marsden NHS Foundation Trust
South Tyneside and Sunderland NHS Foundation Trust
Novartis
Yale University
Eastern Hepatobiliary Surgery Hospital
University Hospital, Bordeaux